You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Efficacy of mycophenolate mofetil as a remission induction therapy in antineutrophil cytoplasmic antibody-associated vasculitis—a meta-analysis

Article info

Article menu

Download PDFPDF

Vasculitis
Original research
Efficacy of mycophenolate mofetil as a remission induction therapy in antineutrophil cytoplasmic antibody-associated vasculitis—a meta-analysis

Authors

  • Kentaro Kuzuya Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Japan PubMed articlesGoogle scholar articles
  • Takayoshi Morita Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, JapanLaboratory of Immunopathology, World Premier International Immunology Frontier Research Center, Suita, Japan PubMed articlesGoogle scholar articles
  • Atsushi Kumanogoh Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, JapanLaboratory of Immunopathology, World Premier International Immunology Frontier Research Center, Suita, JapanIntegrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Japan PubMed articlesGoogle scholar articles
  1. Correspondence to Takayoshi Morita; t-morita{at}imed3.med.osaka-u.ac.jp
View Full Text

Citation

Kuzuya K, Morita T, Kumanogoh A
Efficacy of mycophenolate mofetil as a remission induction therapy in antineutrophil cytoplasmic antibody-associated vasculitis—a meta-analysis
RMD Open 2020;6:e001195. doi: 10.1136/rmdopen-2020-001195

Publication history

  • Received January 28, 2020
  • Revision received March 25, 2020
  • Accepted March 29, 2020
  • First published May 5, 2020.
Online issue publication 
May 29, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.